Immune Response to Recombinant Plasmid Expressing the Ag85BEsat6-HspX Fusion Protein in Mice
CSTR:
Author:
Affiliation:

Key Laboratory of Human Disease Comparative Medicine,Ministry of Heath,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences & Peking Union Medical College,Human Disease Animal Models Level-3 Laboratory of State Administration of Traditional Chinese Medicine,Beijing 100021,China

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To study immunogenicity of fusion gene Ag85B-Esat6-HspX of Mycobacterium tuberculosis. Methods Forty BALB / c mice were randomly divided into four groups (10 per group) : the plasmid pcDNAHspX group,the pcDNA-Ag85B-Esat6-HspX plasmid group,the BCG group and the saline group. The immunization was repeated three times two weeks apart. A single dose of BCG (1 × 106 CFU /mouse) was injected subcutaneously. Mice in other three groups were administered intramuscularly in the hind limb. Total IgG levels were detected at 2,4 and 6 weeks after immunization. Meanwhile,cell-mediated immunity responses were examined two weeks after the final immunization as well. Result Mice immunized with recombinant plasmid expressing the Ag85B-Esat6-HspX fusion protein generated specific cellular and humoral immunologic response to the stimulation of Ag85B,Esat6 and HspX. Conclusion The fusion gene Ag85B-Esat6-HspX of Mycobacterium tuberculosis could be DNA vaccine to carry out the further research of protective efficacy.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 22,2011
  • Revised:
  • Adopted:
  • Online: November 25,2025
  • Published:
Article QR Code